<DOC>
	<DOCNO>NCT00968032</DOCNO>
	<brief_summary>The foramen ovale open interatrial septum . It result incomplete coverage ostium secundum . In 10 24 % general population incomplete fibrosis interatrial septum clinical finding define patent foramen ovale ( PFO ) . The Nit-Occlud® PFO umbrella permanent implant closing PFOs implant PFO use minimally invasive catheter technology . The umbrella make Nitinol , material superelastic property , , relaxed state , form double umbrella . This single-center , non-comparative , prospective interventional clinical investigation involve 1 center Germany ass effectiveness , safety practicability implantation Nit-Occlud PFO® Closure Device .</brief_summary>
	<brief_title>Procedural Success Safety Nit-Occlud® Patent Foramen Ovale ( PFO ) Closure Device Its Application System</brief_title>
	<detailed_description />
	<mesh_term>Foramen Ovale , Patent</mesh_term>
	<mesh_term>Heart Septal Defects</mesh_term>
	<mesh_term>Heart Septal Defects , Atrial</mesh_term>
	<criteria>Diagnosis patent foramen ovale ( PFO ) 1 . Age 18 65 year gender 2 . Ability give write informed consent tell potential benefit risk enter trial understand plan clinical study able participate followup procedures 3 . Signed informed consent 4 . Presenting neurological symptom least one follow clinical circumstance : Diagnosis cryptogenic stroke base clinical neurological examination Diagnosis transient ischemic attack ( TIA ) base clinical neurological examination 5 . PFO defect without atrial septal aneurysm balloon stretch diameter less 18 mm . PFO tunnel length le 10 mm TEE 6 . Mental physical ability patient follow protocol accord compliance time schedule , treatment plan , completion CRF page study procedure . 1 . PFO dimension exceed Inclusion criterium 5 ) 2 . Active endocarditis 3 . Presence infectious disease 4 . Vascular anatomy unable accommodate appropriatesized sheath device introduction 5 . Current arrhythmia , history arrhythmia 6 . Prior cardiac surgery , include implantation active nonactive cardiac device ( coronary stent allow ) 7 . Confinement bed ( high potential clot formation ) 8 . Heart abnormality PFO 9 . Accessory atrial defect 10 . Participation investigational drug device trial within 30 day prior selection , current inclusion clinical trial research project 11 . Known allergy nickel 12 . Known allergy contrast agent 13 . Cancerogenic disease malignant tumor , severe disease 14 . Intracardiac mass vegetation 15 . Thrombus intend site implant document evidence venous thrombus vessel access defect gain 16 . Unable tolerate Aspirin Clopidogrel , and/or antibiotic prophylaxis least three month follow procedure 17 . Pregnant breast feed female patient 18 . Subjects , opinion investigator , inappropriate inclusion trial comply requirement study 19 . Subjects imprison ( accord MPG § 20.3 ) 20 . Patients lawfully keep institution</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>PFO</keyword>
	<keyword>Patent Foramen Ovale</keyword>
</DOC>